-

Viz.ai Wins Comparably Awards for Best Place to Work for Third Consecutive Year

Healthcare AI leader recognized for its outlook, leadership and career growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has been named a Best Place to Work by Comparably, a leading workplace culture and compensation monitoring employee review platform, for three consecutive years. The Company received three Comparably Best Place to Work Awards in 2024 for Best Company Outlook, Best Leadership Teams and Best Career Growth.

"We are thrilled that Viz.ai has been recognized with three distinguished awards for our exceptional workplace culture. These accolades reflect the dedication and hard work of our team as well as our unwavering commitment to expanding access to life-saving treatments," said Dawn Sprague, vice president of People at Viz.ai. "Our primary goal is to cultivate an environment where everyone can thrive and develop, and we remain dedicated to investing in a culture that supports each individual's ambitions and personal growth."

Viz.ai ranks in the top 5% of other companies on Comparably with 201-500 employees for overall company culture. Out of 492 Viz.ai employee reviews, 93% were positive. In an anonymous survey, one Viz.ai team member shared, “Viz provides a dynamic and empowering work environment. The flexibility with work hours and wellness days foster a healthy work-life balance, and the remote structure encourages autonomy. Overall, it's been an enriching experience that values individual contributions while promoting adaptability.”

Comparably recognizes exceptional companies with the Best Place to Work Awards based on anonymous employee ratings about their workplaces over a 12-month period. The final data set was compiled from over 20 million ratings across 70,000 companies.

To learn about opportunities to join Viz.ai, please visit https://www.viz.ai/careers.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai OneTM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Media
Olivia Schlabach
olivia.schlabach@finnpartners.com

Viz.ai


Release Versions

Contacts

Media
Olivia Schlabach
olivia.schlabach@finnpartners.com

Social Media Profiles
More News From Viz.ai

A Decade of Increasing Access to Life Saving Treatments: Viz.ai Celebrates 10 Years, 2,000 Hospitals, and 230 Million Patients

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today celebrates its 10th anniversary, marking a decade of transforming how healthcare teams deliver care for patients. The company launched in 2016 to solve a key problem: variability in healthcare means that many patients fail to get guideline based care, even in life threatening diseases like stroke. Since achieving the first FDA clearance for an AI platform and increasing tr...

Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial, a prospective, multicenter, randomized study evaluating whether the SCUBA technique, an endoscopic, catheter-based approach for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH), is a promising alternative to standard medical management to pote...

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growi...
Back to Newsroom